Stanford's Kyle Loh Wins ISSCR Early Career Award for Precision Stem Cell Differentiation Methods

How do you turn a pluripotent stem cell - a cell with the potential to become almost anything - into exactly the cell type you need, reliably and at high purity? That technical challenge underlies nearly every application of human pluripotent stem cell biology, from disease modeling to drug screening to therapeutic development. Kyle Loh at Stanford University has spent his early career finding systematic answers to that question, and the results have reached well beyond the laboratory bench.

The International Society for Stem Cell Research named Loh the recipient of the 2026 ISSCR Early Career Impact Award, supported by the Tianqiao and Chrissy Chen Institute. He will present his work at ISSCR 2026 in Montreal from 8-11 July. Four honorable mention recipients were also recognized.

A Systematic Approach to Cell Fate

Standard differentiation protocols in the field often produce impure mixtures of cell types or require lengthy, empirically derived procedures that work for one cell type but must be entirely re-developed for the next. Loh's laboratory took a different approach: systematically identifying the lineage-specific progenitor cells and the extracellular signals that govern fate decisions at each branch point in development, then using that mechanistic understanding to engineer concise, high-purity protocols.

The result is a toolkit covering more than two dozen endodermal, mesodermal, and ectodermal cell types - spanning the three primary germ layers that give rise to all organs in the body. The benchmark achievement is arterial and venous endothelial cells generated at greater than 90 percent purity within days. That level of purity is not merely a technical achievement; it is a prerequisite for using those cells in experiments where contaminating populations would confound the results or in therapeutic applications where off-target cells could cause adverse effects.

Those protocols have been adopted by laboratories worldwide, enabling research that would previously have required years of method development to begin at all.

A Virus and a Blood Vessel Type

Using the high-purity arterial and venous endothelial cells his protocols produce, Loh bridged stem cell biology into virology. His laboratory demonstrated that the Nipah virus - a bat-borne paramyxovirus with a fatality rate between 40 and 75 percent in outbreak settings - preferentially infects arterial endothelial cells rather than venous ones. This was the first experimental demonstration that a virus can show tropism for a specific type of blood vessel at the cellular level, with implications for understanding the hemorrhagic pathology of Nipah infection and potentially for antiviral development.

Rethinking Brain Development

Loh's work also reached into neuroscience. His laboratory discovered that the forebrain and midbrain arise from a different progenitor during gastrulation than the hindbrain does - a distinction that turns out to have been conserved across more than 500 million years of vertebrate evolution. That finding has implications for understanding both normal brain development and the specific developmental defects that underlie certain neurological conditions.

Mentorship and Access

The award citation specifically highlights Loh's approach to mentorship. Drawing on his own background as a community college student, he has personally trained students from underrepresented backgrounds and minority-serving institutions, many of whom have gone on to coauthor papers in high-impact journals and pursue graduate and research careers in STEM. His laboratory is described as having a deliberately non-hierarchical structure that gives trainees at early career stages meaningful research responsibility.

The 2026 honorable mention recipients are Faranak Fattahi at UCSF, recognized for stem cell models of the peripheral nervous system and enteric organoids; Kara McKinley at Harvard and HHMI for redefining endometrial biology and uterine regeneration; Naomi Moris and Nicolas Rivron (Francis Crick Institute and IMBA Vienna) for developing gastruloids and blastoids as embryo models with integrated ethical governance; and Giorgia Quadrato at USC Stem Cell for brain organoid protocols that have reshaped understanding of autism spectrum disorders at the developmental biology level.